These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2459952)

  • 1. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma.
    Ordóñez NG; Ji XL; Hickey RC
    Am J Clin Pathol; 1988 Oct; 90(4):385-90. PubMed ID: 2459952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
    Wick MR; Swanson PE; Rocamora A
    J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
    Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
    Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
    Steuhl KP; Rohrbach JM; Knorr M
    Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibody HMB-45 in the cytologic diagnosis of melanoma.
    Ordóñez NG; Sneige N; Hickey RC; Brooks TE
    Acta Cytol; 1988; 32(5):684-8. PubMed ID: 3048028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections.
    Duray PH; Palazzo J; Gown AM; Ohuchi N
    Cancer; 1988 Jun; 61(12):2460-8. PubMed ID: 3365669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibody HMB-45 in diagnosis of intra-ocular melanoma].
    Rohrbach JM; Steuhl KP; Thanos S
    Klin Monbl Augenheilkd; 1991 Oct; 199(4):274-7. PubMed ID: 1762354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi.
    Shah IA; Gani OS; Wheler L
    Pathol Res Pract; 1997; 193(7):497-502. PubMed ID: 9342756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of S-100 beta in choroidal melanomas.
    Martins MC; Scull JJ; Alcocer CE; Deschênes J; Antecka E; Burnier MN
    Can J Ophthalmol; 1997 Oct; 32(6):378-81. PubMed ID: 9363341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
    Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
    Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
    Kanik AB; Yaar M; Bhawan J
    J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.
    Luyten GP; Mooy CM; Post J; Jensen OA; Luider TM; de Jong PT
    Cancer; 1996 Nov; 78(9):1967-71. PubMed ID: 8909318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen.
    Xu X; Azumi N; Skelton HG; Hearing VJ; Gersten DM
    Eur J Cancer; 1996 Jan; 32A(1):168-73. PubMed ID: 8695227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
    Orchard GE
    Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.